Sat, Dec 20, 2014, 8:06 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Jazz Pharmaceuticals Public Limited Company Message Board

  • daytonapaul01 daytonapaul01 Sep 6, 2010 8:49 PM Flag

    SOMX BUYS JAZZ...WE HAVE A HUGE PIPELINE!

    let these two companies get together to overwhelm this industry and put generic to rest until 2010, These idiots portraying themselves as having knowledge about patents are more lies by the Shorts and probably lunesta, and ambian! There will be no patent ending on this stock until 2020. If an otc wants to try to advance their own cause, they will be bankrupt by our product. WE HAVE A 50 BILLION DOLLAR PRODUCT OVER THE NEXT TEN YEARS AND ANOTHER 50 BILLION OTC! DON't let the worms cut into our rewards..imo dp

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Right, patenting HGB is bulletproof. Jazz couldn't afford to even go to court if a competitor submitted a hgb product for narcolepsey with a slightly different dose. 2 weeks up now it's 2 weeks down. Put buyers and shorts taken out now it's time for all the new shareholders and call buyers to be taken out. $8.50 or lower this week.

 
JAZZ
169.03-0.85(-0.50%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.